Valuation: Beijing Airdoc Technology Co., Ltd.

Market Cap 850M 996M 127M 111M 104M 94.9M 178M 12.16B 178M 1.25B 481M 6.19B 477M 466M 19.98B P/E 2026 *
-22.7x
P/E 2027 * -420x
Enterprise Value 850M 996M 127M 111M 104M 94.9M 178M 12.16B 178M 1.25B 481M 6.19B 477M 466M 19.98B EV / Sales 2026 *
3.37x
EV / Sales 2027 * -
Free-Float
31.5%
Yield 2026 *
-
Yield 2027 * -
1 day-1.30%
1 week+23.28%
Current month+14.53%
1 month-5.29%
3 months-17.50%
6 months-12.05%
Current year-13.82%
1 week 7.68
Extreme 7.685
10
1 month 6.94
Extreme 6.945
10
Current year 6.94
Extreme 6.945
13.77
1 year 6.94
Extreme 6.945
16
3 years 6.94
Extreme 6.945
18.38
5 years 6.94
Extreme 6.945
74.95
10 years 6.94
Extreme 6.945
74.95
Manager TitleAgeSince
Chief Executive Officer 43 2015-09-08
General Counsel - 2021-02-28
Corporate Secretary - 2022-01-18
Director TitleAgeSince
Chairman 43 2015-09-08
Director/Board Member 63 2020-12-24
Director/Board Member 53 2020-12-24
Date Insider Type Main position Quantity % Market Cap. Importance
5/29/26 Other

Chief Executive Officer

-165,400 0.1597%
1/20/26 Other

Chief Executive Officer

418,500 0.4041%
9/24/25 Other

Chief Executive Officer

35,000 0.0338%
Change 5-day change 1-year change 3-year change Capi.($)
-1.30%+23.28%-34.77%-12.05% 129M
+0.42%-1.64%-5.93%+28.60% 42.13B
+0.96%+1.34%-47.61%+133.95% 12.59B
-2.28%-3.74%-13.09%+106.27% 5.65B
-0.83%+1.59%+53.07% - 4.41B
+1.40%+8.62% - - 2.2B
+0.62%-3.22%+3.48%-36.49% 1.47B
+3.45%+3.29%-34.54% - 1.03B
-0.20%-2.53%+17.65%+151.26% 991M
-0.99%+2.76%+39.03%+53.12% 913M
Average +0.16%+3.18%-2.52%+60.67% 7.15B
Weighted average by Cap. +0.33%+0.56%-9.68%+56.91%

Financials

2026 *2027 *
Net sales 252M 295M 37.63M 32.81M 30.9M 28.14M 52.76M 3.61B 52.83M 370M 143M 1.84B 141M 138M 5.93B -
Net income -39M -45.69M -5.82M -5.08M -4.78M -4.36M -8.17M -558M -8.18M -57.28M -22.08M -284M -21.88M -21.39M -917M -
Net Debt - -
Logo Beijing Airdoc Technology Co., Ltd.
Beijing Airdoc Technology Co Ltd is a China-based company primarily engaged in providing artificial intelligence (AI)-empowered retina-based early detection, diagnosis and health risk assessment solutions. The Company’s main products include Myopia Prevention and Control AI (PBM-AI), Retinal Detection AI (Retina AI) and Stress Resilience Monitoring AI (Neuro-AI). The Company offers health risk assessment solutions with the ability to detect risk indicators, including risk assessments of retinal abnormalities, retinal vascular diseases, vitreous abnormalities, retinal tumors, optic nerve pathologies, macular diseases, congenital anomalies of the retina, cardiovascular disease and anemia. The Company conducts its business in the domestic and overseas markets.
Employees
155
Date Price Change Volume
26-09-21 HK$9.850 -1.30% 78,100
26-09-18 HK$9.980 +0.86% 127,400
26-09-17 HK$9.895 +9.94% 313,300
26-09-16 HK$9.000 +1.29% 316,300
26-09-15 HK$8.885 +11.20% 194,100
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
8.407CNY
Average target price
11.22CNY
Spread / Average Target
+33.44%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2251 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!